| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 93,082 | 100,599 | 99,371 | 78,017 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 100,599 | 99,371 | 78,017 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 89,287 | 96,030 | 93,250 | 94,433 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,001 | 1,300 | 1,050 | 1,517 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 562 | 3,269 | 5,071 | (17,933) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,794 | 3,269 | 5,071 | (17,933) | | Interest Expense | 701 | 761 | 770 | 981 | | Income Before Tax | 2,093 | 2,508 | 4,301 | (18,914) | | Income Tax Expense | 212 | 545 | 952 | (7,507) | | Minority Interest | (5) | 20 |
-
|
-
| | | | Net Income From Continuing Ops | 1,861 | 1,983 | 3,349 | (11,407) | | | Non-recurring Events | | Discontinued Operations | 49 | (117) | (237) | (64) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,925 | 1,866 | 3,112 | (11,471) | | Preferred Stock And Other Adjustments |
-
| (7) | 7 |
-
| | | Net Income Applicable To Common Shares | $1,925 | $1,859 | $3,119 | ($11,471) |
|
0.40% Nasdaq 
Income Statement
